U.S. COMPANY FILING
BOSTON SCIENTIFIC CORP — Form 10-Q filed 2025-11-03
Filing text preview
Boston Scientific reported Q3 2025 net sales of $5.065 billion, up 20% YoY, and net income of $755 million, up 61%. For the nine months, net sales were $14.788 billion, up 21%, and net income was $2.226 billion, up 73%. The company completed several acquisitions, including Bolt Medical, SoniVie, and Intera Oncology, and issued euro bonds. Both Cardiovascular and MedSurg segments grew.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record